Clinical Trial Update: A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine [Phase 2]

View source ↗

Summary

Phase II dose-ranging study of oral RV3-BB rotavirus vaccine completed; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infections

Drugs mentioned

• RV3-BB rotavirus vaccine

Snippet

Sponsor: Murdoch Childrens Research Institute | Conditions: Rotavirus Infections | Phase 2 | Status: COMPLETED | Results posted: 2023-07-10